Viorel G. Florea, Inder S. Anand

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Epidemiologic, clinical, and basic research has identified several antecedent conditions that predispose individuals to heart failure and its predecessor, asymptomatic left ventricular remodeling and dysfunction (stage B heart failure). Many biochemical markers have been described that characterize the remodeling process and the development of cardiac dysfunction. Although natriuretic peptides and cardiac troponin are currently used in the context of diagnosis, risk stratification, and management of stage C and D heart failure, many other biomarkers provide insights into the underlying pathophysiology of left ventricular dysfunction, suggesting new directions for fundamental research or the development of new therapies.

Original languageEnglish (US)
Pages (from-to)207-224
Number of pages18
JournalHeart Failure Clinics
Issue number2
StatePublished - Apr 2012


  • Biomarkers
  • Brain natriuretic peptide
  • Heart failure
  • Troponin


Dive into the research topics of 'Biomarkers'. Together they form a unique fingerprint.

Cite this